News from the healthcare data industry
The EHDEN project’s recent call for more data made a specific appeal for cancer and immunology records, as well as partners from underrepresented countries The goal of EHDEN is to...
March 28, 2022 – Mitsui & Co., Ltd. (“Mitsui”, Head Office: Tokyo, President and CEO: Kenichi Hori) and TriNetX, LLC (“TriNetX”, Head Office: Massachusetts, U.S., CEO: Gadi Lachman), the global network...
Cascador Health will utilise the new funding to scale its activities in Belgium and Switzerland and expand in Europe Megha Paul 25 March 2022 Belgian health tech startup Cascador Health has raised...
Abstract Aims: Using German claims, the authors replicated the CHAARTED trial in metastatic hormone-sensitive prostate cancer. Methods: The authors identified metastatic hormone-sensitive prostate cancer patients replicating the inclusion/exclusion criteria of CHAARTED. Patients treated...
22 Mar 2022 Francesca Bruce@ScripFrancesca Francesca.bruce@informa.com Executive Summary England’s health technology appraisal body, NICE, will publish a framework that will help it deliver on its ambition to use real-world evidence to...
SHANGHAI, March 14, 2022 /PRNewswire/ — Asieris Pharmaceuticals (688176.SH), a global innovative biopharma company specializing in discovering and developing innovative drugs for the treatment of genitourinary tumors and other major diseases, announced that the...
When inspecting clinical trials that incorporate real-world data, the UK medicines regulator says that its good clinical practice (GCP) inspectors expects sponsors to be able to demonstrate that the RWD...
Report Prepared by the Oncology Industry Taskforce RWE Working Group, a Medicines Australia Initiative Read the Report here: https://www.medicinesaustralia.com.au/wp-content/uploads/sites/65/2020/11/OIT-RWE-Report-Oct-2020-FINAL-MA-VERSION.pdf
Background: Abiraterone and enzalutamide are widely used as first-line treatment for metastatic castration-resistant prostate cancer (mCRPC); however, their efficacy in mCRPC has been inconsistently demonstrated in other outcome studies from real-world...
Ariel D Stern 1, Jan Brönneke 2, Jörg F Debatin 2, Julia Hagen 2, Henrik Matthies 2, Smit Patel 3, Ieuan Clay 4, Bjoern Eskofier 5, Annika Herr 6, Kurt Hoeller 7, Ashley Jaksa 8, Daniel B Kramer 9, Mattias Kyhlstedt 10, Katherine T Lofgren 11, Nirosha Mahendraratnam 12, Holger Muehlan 13, Simon Reif 14, Lars Riedemann 15, Jennifer C Goldsack 3 Affiliations 1Technology and Operations Management...